Company page
Bioarctic Ab Class B
Bioarctic Ab Class B is a publicly traded company based in Sweden, with a market capitalization of approximately 2.76 billion SEK. The company is focused on developing innovative therapies for neurodegenerative diseases. As part of its commitment to advancing healthcare, Bioarctic aims to address significant unmet medical needs in this field.
- Ticker
- BIOA_B:OMXSTO
- Asset type
- Stock
- Market cap
- $2.76B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK